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Abstract
Harlequin Ichthyosis (HI) is a severe and often lethal hyperkeratotic skin disease caused by mutations in the ABCA12
transport protein. In keratinocytes, ABCA12 is thought to regulate the transfer of lipids into small intracellular trafficking
vesicles known as lamellar bodies. However, the nature and scope of this regulation remains unclear. As part of an original
recessive mouse ENU mutagenesis screen, we have identified and characterised an animal model of HI and showed that it
displays many of the hallmarks of the disease including hyperkeratosis, loss of barrier function, and defects in lipid
homeostasis. We have used this model to follow disease progression in utero and present evidence that loss of Abca12
function leads to premature differentiation of basal keratinocytes. A comprehensive analysis of lipid levels in mutant
epidermis demonstrated profound defects in lipid homeostasis, illustrating for the first time the extent to which Abca12
plays a pivotal role in maintaining lipid balance in the skin. To further investigate the scope of Abca12’s activity, we have
utilised cells from the mutant mouse to ascribe direct transport functions to the protein and, in doing so, we demonstrate
activities independent of its role in lamellar body function. These cells have severely impaired lipid efflux leading to
intracellular accumulation of neutral lipids. Furthermore, we identify Abca12 as a mediator of Abca1-regulated cellular
cholesterol efflux, a finding that may have significant implications for other diseases of lipid metabolism and homeostasis,
including atherosclerosis.
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Introduction
Harlequin ichthyosis (HI, OMIM 242500) is a rare and
devastating congenital disorder characterised by premature
delivery and thick, hyperkeratotic, ‘armour’-like skin plaques.
This immobile skin or ‘collodion membrane’ constricts the embryo
causing odema, limb contractures and eversion of the eyelids and
lips. Despite the provision of neonatal intensive care to ameliorate
dehydration and the application of high-dose retinoid therapy [1],
many infants die from respiratory distress, bacterial infections and
feeding difficulties [2]. In surviving patients, the skin barrier
dysfunction remains, leading to excessive transepidermal water
loss, impairment of thermal regulation and an increased risk of
cutaneous infection. The gross phenotypic and barrier defects in
HI are thought to primarily result from abnormal lipid metabolism
in the epidermis.
In mammalian skin the outer layer, or stratum corneum,
maintains barrier function. Within this layer, corneocytes are
embedded in a lamellar intercellular lipid complex of cholesterol,
phospholipids and ceramides. Small, specialised vesicular struc-
tures known as lamellar bodies (LBs) are thought to traffic many of
these components to the surface of differentiating keratinocytes
[3]. Ceramides contribute to both lamellar extracellular lipids and
to a covalently attached lipid layer known as the corneocyte lipid
envelope (CLE) [4]. They are derived primarily from the
conversion of glucosylceramides through the action of b-
glucocerebrosidase [5] and to a lesser extend by the conversion
of sphingomyelin by sphingomyelinase [6]. Most ceramide
processing in the stratum corneum is thought to occur extracel-
lularly after docking of the LBs with the cell surface, however
significant levels of glucosylceramides and ceramides are found
within the cell and in other layers of the epidermis [7].
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ATP binding cassette A12 (ABCA12) gene cause HI [8,9]. The ABC
proteins are thought to act primarily as transporters of molecules
across cellular membranes and like other family members ABCA12
encodes a polytopic transmembrane (TM) protein comprising at
least 12 TM domains and 2 ATP binding cassettes. Mutations in
ABCA12 are also associated with a less severe disease known as
lamellar ichthyosis-2 (LI2, OMIM 601277)[10]. Initial studies of
these conditions indicate that LI2 is caused by missense,
potentially hypomorphic, mutations in or near the first ATP
binding domain (NBD1) whereas HI is associated with mutations
that either abolish ABCA12 protein production or produce a
protein with severely impaired function [8–10].
The co-localisation of ABCA12 with LBs [11], the common
malformation of these organelles in HI [12], the mis-localisation of
glucosylceramide in HI keratinocytes and the correction of this
abnormality by ABCA12 expression [8] present prima facie
evidence that the protein plays an active role in trafficking lipids
into LBs. More specifically, the abnormal LBs in HI granular layer
keratinocytes and lack of extra-cellular lipid lamellae in patients
imply that lipid transport to the intercellular lamella is disrupted.
Despite these observations the nature and scope of Abca12’s
involvement in lipid homeostasis remain unclear. Several of the 48
member ABC protein family are known to play critical roles in
controlling lipid levels, primarily by mediating their efflux from the
cell. Cholesterol metabolism is perhaps the best studied of these
pathways, as defects in clearance of cholesterol from vascular cells
constitute a key element in the development of atherosclerosis.
ABCA1, in particular, is considered the primary mediator of
cholesterol efflux and mutations in the gene are associated with
reduced cholesterol efflux and absent reverse cholesterol transport
in both humans (Tangier disease) and in animal models [13–15].
Genetic studies in the mouse have proven to be a very powerful
approach to understanding human diseases that affect embryonic
development. We have undertaken a genotype driven ENU screen
which identifies pedigrees in which mice die embryonically or
neonatally, irrespective of the cause or timing of death, and
simultaneously maps the causative mutations within the genome.
Using this strategy we have identified a pedigree carrying a
mutation in one of the transmembrane domains of Abca12. Pups
homozygous for the mutation die shortly after birth and show
hallmarks of HI including hyperkeratosis, abnormal extracellular
lipid lamellae and defects in cornified envelope processing. We
have used this model to follow disease progression in utero and we
report profound defects in lipid homeostasis demonstrating the
extent to which Abca12 plays a pivotal role in maintaining the
skin’s lipid balance. Our study identifies Abca12 as a key regulator
of lipid transport and homeostasis, and describes specific lipid
efflux functions, including that of cholesterol, with broader
implications for other lipid-related metabolic disorders.
Results
A Novel Recessive ENU Mutagenesis Screen Identifies an
Animal Model of HI
Mutations that cause recessive lethality in embryos or neonates
(and markers to which they are closely linked) are homozygous at
reduced frequency among adults. This banality formed the basis of
a genetic screen to identify genes required for mouse development
(Figure 1A). Briefly, 129/Sv male mice were injected with ENU
and mated to C57BL/6 females. Their first-generation (G1) male
progeny were again crossed to C57BL/6 females, and then
backcrossed to one of their second-generation (G2) daughters to
yield a third-generation (G3). For those pedigrees in which 20 or
more G3 mice were generated, the sperm of the founding G1
mouse was frozen. Adult G3 mice were genotyped with a panel of
simple sequence length polymorphic markers and regions in which
no animals showed homozygosity of the 129/SV alleles, despite
both parents being heterozygous, were highlighted as being linked
to a potential recessive lethal ENU-induced mutation. The
presence of recessive lethal mutation was then confirmed by
generating and genotyping a second cohort of G3 animals from the
frozen sperm of the founding G1 male.
In our initial screen, we set up 40 G1 male mice to breed and
generated 18 pedigrees that contained more than 20 G3 mice. To
prove the principle of the approach, we have proceeded with one
pedigree, Embryonic Lethal 12 (EL12). In this pedigree, we found
129/SV alleles that were absent in all of the adult G3 mice.
Notably, among 34 G3 EL12 mice, we observed none that were
homozygous for the129/Sv allele of D1Mit156, even though both
parents were heterozygous for the 129/Sv allele of this marker.
This was confirmed in a second cohort of 31 G3 mice. Using a
total of 463 mice and 13 polymorphic markers, we refined the
interval harboring the lethal mutation to 4.7 Mb between
D1Mit178 and D1Mit482 (Figure 1B). We sequenced the exons
and intron/exon boundaries of the 13 genes in the candidate
interval and found a single G to A transition of exon 41 of Abca12
(Figure 1C). Abca12 is a member of the ABC transporter family of
proteins, and the mutant allele (Abca12
el12) results in a point
mutation (G1997D) in the first helix of the protein’s second
transmembrane array (Figure 1D) which is highly conserved in a
diverse range of organisms (Figure 1E).
Abca12
el12//el12 Mice Die Neonatally
Consistent with the results of the genetic screen, at weaning no
Abca12
el12/el12 mice were detected from heterozygous crosses
however examination of litters at E18.5 found normal mendelian
ratios of viable but phenotypically abnormal Abca12
el12/el12
embryos (n=17/57 embryos). Abca12
el12/el12 pups were occasion-
ally found in the first few hours after birth but were often dead or
severely dehydrated and had failed to suckle normally. Recent
studies by Yanagi et al., indicate a role for Abca12 in lung
development and defects in this organ may contribute to neonatal
death [16]. To follow the development of the phenotype we
Author Summary
Harlequin Ichthyosis is a severe inherited disease in which
the skin develops as thick armour-like plates. While many
HI patients die at birth, those who survive are subject to
dehydration and infection. The disease is caused by
defects in a protein called ABCA12, which is thought to
function by transporting lipids within the cells of the skin.
Here, we describe a new genetic screen that we have used
to identify a mouse model that develops the hallmarks of
HI and carries a mutation in Abca12. We have used this
model to elucidate Abca12’s significant role in the
transport of lipids within the skin, and we demonstrate
that the loss of these lipids contributes to the dehydration
in affected embryos and newborns. We attribute specific
transport functions to the protein and show that it can
mediate the efflux of a number of different lipids from the
cell including, importantly, cholesterol. Cholesterol trans-
port by proteins related to Abca12 plays a critical role in
the development of a number of diseases, including heart
and peripheral vascular disease, and the description of
these functions for Abca12 suggest that it may play a
wider role in controlling lipid metabolism.
Abca12’s Role in Lipid Homeostasis
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At E14.5 and E15.5 homozygous embryos appeared normal;
however from E16.5 onwards they were characterised by an
absence of normal skin folds around the trunk and limbs. As
development progressed, Abca12
el12/el12 embryos developed a taut,
thick epidermis and multiple contractures affecting the limbs
(Figure 2A,3A). Late stage Abca12
el12/el12 embryos were also found
to be smaller than their wild type or heterozygous littermates
(Figure 2A, 3A), a phenotype we assayed in newborn mice
(p=0.0023, data not shown). Skin sections from affected embryos
revealed a hyperkeratotic phenotype from E16, and confirmed the
absence of normal folding (Figure 2B).
Histologically all epidermal cell layers were apparent in
Abca12
el12/e1l2 embryos, although the size of the granular layer
progressively increased at the expense of the spinous layer
(Figure 2B, 5A). By parturition the cornified layers had coalesced
Figure 1. An ENU recessive mutagenesis screen identifies a lethal mutation Abca12. Mutagenised 129/Sv males were crossed with C57BL/6
females and the resultant G1 males crossed again to C57BL/6. Pedigrees were established by crossing G1 males with their G2 daughters and the G3
offspring were then subjected to genome wide screening for absence of homozygosity of the mutagenised (129/Sv) strain (A). The recessive embryo
lethal 12 (el12) mutation was identified using this approach and mapped by recombination to Chromosome 1 (B). Open rectangles indicate
haplotypes homozygous for the 129/Sv mutagenised background and filled rectangles are C57BL6/J homozygotes or heterozygotes. Recombination
frequency and markers position are indicated. A missense G1997D mutation was identified in Abca12 (C, D). The el12 mutation alters a residue in the
second TM region of the protein which is conserved in all species examined (human, mouse, dog, chicken, platypus, microbat and shrew) (E).
doi:10.1371/journal.pgen.1000192.g001
Figure 2. The Abca12
el12/el12 phenotype. Abca12
el12/el12 mice display an epidermal phenotype visible from E16.5 and by E18.5, the thickening of
the cornified envelope produces a constrictive, taut and shiny epidermis resulting in limb contractures (A). Sections of epidermis at E17.5 and birth
demonstrate severe hyperkeratosis characterised by the formation of a 20–30 cell layer thick stratum corneum. Cell architecture in other layers of the
epidermis is also affected, with a reduction in the size of the spinous cell layer and lack of dense palisaded basal cell nuclear architecture (B).
doi:10.1371/journal.pgen.1000192.g002
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in Abca12
el12/el12 mice also lost the dense palisaded nuclear
organisation apparent in wild type and Abca12
el12/+ mice
(Figures 2B, 4A). Consistent with the apparently restrictive nature
of the cornified layer, the epidermis as a whole was 30% thinner at
E17.5 and P1 in Abca12
el12/el12 animals (data not shown). Despite
this constriction, hair follicles formed and differentiated relatively
normally (Figure 2B, 3F) and complete histological examination of
E18.5 embryos did not identify overt anomalies in other organs.
Adult and embryonic Abca12
el12/+ mice had no overt phenotype,
no obvious histological abnormalities and were healthy and fertile.
Abca12
el12/el12 Mice Have a Defect in Skin Barrier Function
As the Abca12
el12/el12 mice apparently died from dehydration,
we tested skin barrier function which normally initiates in the
mouse from E16, and acquires almost full adult function by E18.5
[17]. We measured permeability of E18.5 embryos against the dye
toluidine blue and found that Abca12
el12/el12 embryos had uniform
absence of barrier function (Figure 3A). To determine if this defect
contributed to the dehydration observed in homozygous animals
we harvested the dorsal epidermis from E18.5 embryos and
measured the ability of the skin to retain water using a trans-
epidermal water loss (TEWL) assay over a 5 hour time course. A
significant difference in TEWL from Abca12
el12/el12 embryos was
observed as early as 60 minutes (Figure 3B), confirming that
mutations in Abca12 in mice also lead to the defects in barrier
formation that are observed in HI patients.
Defects in the Cornified Envelope of Abca12
el12/el12 Mice
HI patients develop a thick armour like stratum corneum and a
suite of defects in the biochemistry of this layer. To examine the
stratum corneum we harvested cornified envelopes (CE) from
E18.5 embryonic skin. In wild type mice, large squames were
present in expected numbers whereas Abca12
el12/el12 mice were
found to have sparse CEs which were both small and unable to
structurally withstand the purification procedure (Figure 3C,D).
While the levels of filaggrin in the epidermis of E18.5 Abca12
el12/
el12 mice were slightly increased, its processing into a functional
27 kDa monomer was ablated (Figure 3E) as has previously been
observed in HI patients [18], indicating that normal LB and
Abca12 function is required for this process. The level of other
barrier proteins such as loricrin was unaffected (Figure 3E, data
Figure 3. Barrier defects in Abca12
el12/el12 mice. Abca12
el12/el12 mice have defects in barrier formation as evidenced by dye exclusion (A) and
trans-epidermal water loss (B) assays at E18.5. Cornified envelopes prepared from Abca12
el12/el12 mice are fragile and reduced in size compared with
wild type littermate controls (Abca12
el12/el12 CEs concentrated 15 times, C, D: p=6610
223). Western blotting indicates defects in filaggrin processing
in Abca12
el12/el12 epidermis (E, arrow) while expression of other CE proteins such as loricrin is unaffected. Expression of ‘‘proliferative’’ keratin VI is
present only in the differentiating hair follicle of both mutant and wild type epidermis (F) and cell proliferation at E17.5 is normal as assayed by
phospho-histone H3 staining (G; p=0.27).
doi:10.1371/journal.pgen.1000192.g003
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keratinocytes has been noted in some studies of HI skin [18], no
aberrant expression of this hyperproliferative marker was detected
in Abca12
el12/el12 mice (Figure 3F). These observations suggest that
the hyperkeratotic phenotype in these animals is not a result of
increased cell proliferation in the basal epidermal layer. To
confirm these findings we surveyed cell proliferation and apoptosis
from E17.5 to P1 (using Ki67, PCNA, phospho-histone H3 and
TUNEL staining) and found no significant differences (Figure 3G,
data not shown).
Abca12
el12/el12 Epidermis Undergoes Premature
Differentiation
Many defects of barrier function have profound impacts on the
epidermis as a whole. We were able to show by histology that
alterations in both nuclear organisation and cellular architecture of
the basal cell layer characterises Abca12
el12/el12 embryos and
postpartum epidermis. We investigated expression of markers of
basal and differentiating keratinocytes during this period and
observed normal levels of Abca12 staining in epidermal cells in the
uppermost granular and cornified layers of the epidermis
(Figure 4A), in a pattern similar to that observed in developing
human skin [19]. Expression of filaggrin, which usually marks the
granular layer of the epidermis, was detected in keratinocytes
juxtaposed to the basal layer itself and in some cells expressing
keratin 14 (Figure 4B). Additionally, we demonstrated a significant
increase in basal (and spinous) layer keratinocytes dually
expressing keratins 10 and 14 (Figure 4C,D). These observations
indicate that keratinocytes in affected epidermis undergo prema-
ture differentiation, either as a result of defects in the cornifying
layer which overlies them or as a consequence of defects in the
balance of intracellular lipids in these cells.
Abca12
el12/el12 Keratinocytes Have LB Defects
Thin sections of affected epidermis highlighted the striking
hyperkeratosis in Abca12
el12/el12 epidermis (Figure 5A). To
investigate Abca12 mediated alterations in epidermal lipid
composition we stained the epidermis with the lipophilic dye Nile
Red. Abca12
el12/el12 mice displayed very little of the normal lipid
deposition in intercellular spaces of the cornified envelope
(Figure 5B). To confirm these effects at an ultrastructural level
we performed transmission electron microscopy on epidermal
tissue at E18.5, utilising ruthenium tetroxide postfixation of thin
epidermal sections [20] to investigate the lamellar lipids which
normally surround cells of the stratum corneum. We demonstrated
an absence of these elements in the spaces between the corneocytes
and cornified/granular layer (Figures 5C–F), although the CLE
was still apparent in Abca12
el12/el12 tissues, an observation
previously observed in HI biopsies [21] (data not shown). The
absence, relative scarcity or malformation of LBs is particularly
characteristic of HI [18,22–25]. While relatively scarce structures
resembling LBs were apparent within the granular layers in
Abca12
el12/el12 animals (Figure 5E,F), most lacked the multilayered
lamellar cargos present in control skin (Figure 5D). Fusion of LBs
with the surface of the normal granular cells was commonly
observed in wild type skin (Figure 5C) and occurred occasionally in
affected epidermis (Figure 5F). Normally, corneocytes are filled
with uniformly opaque keratin-filaggrin protein, however in
affected epidermis they contained numerous vesicular and lamellar
structures (Figure 5H,I), defects found in both in situ and
reconstituted HI epidermis [19,21,26]. Whilst our cellular and
biochemical analysis suggested that some aspects of cornified cell
envelope formation were disrupted in homozygous mice we did
not observe overt differences in this structure during our EM
studies. Indeed EM studies show that as well as a normally formed
Figure 4. Pathology of the Abca12 mutant epidermis. Abca12 protein is detected in suprabasal keratinocytes in the granular and cornified cell
layers of mutant and wild type epidermis (A). Keratinocytes in Abca12 mutant skin undergo premature differentiation highlighted by strong filaggrin
expression in cells juxtaposed to K14
+ basal keratinocytes (B) and increased co-expression of keratins 10 and 14 (white arrows), especially in basal cells
(yellow arrows) (C). Increases in co-expression of K10 and K14 are significant at both E18.5 (p=0.016) and at P1 (p=4.44610
26) (D). Samples are of
E18.5 (A) or P1 (B, C) epidermis counterstained with DAPI. Scale bars=30 mm.
doi:10.1371/journal.pgen.1000192.g004
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corneodesmosomes in the distal layers of the stratum corneum
(Figure 5G,H). The persistence of these structures provide a
mechanistic basis for the hyperkeratotic phenotype in our animals
and serves to explain the relative decrease in extraction of CE’s as
noted above. The epidermis of the Abca12 homozygous mice bear
many if not all of the features of HI, establishing them as an
excellent model in which to study the biochemical basis of this
disease.
Defects in Lipid Homeostasis in Abca12
el12/el12 Epidermis
While previous studies of cultured human HI keratinocytes have
identified defects in the traffic of glucosylceramides, global analysis
of defects in lipid homeostasis, either in vitro or in vivo, have not
been performed. We therefore utilised the Abca12
el12 model to
examine whether defects in lipid homeostasis were apparent in our
mice. We harvested whole epidermis from the mid-dorsum of
E18.5 homozygous, heterozygous and wild type littermates and
empirically assayed for levels of a panel of thirteen different lipid
species. Consistent with reports that Abca12 regulates the
trafficking of glucosylceramide we detected greater than 2-fold
increases in this lipid species in Abca12
el12/el12 epidermis
(Figure 6A). We also detected striking increases in the relative
levels of all ceramide species in affected versus wild type skin
with highest proportional differences in C18, C20 and C22
species, indicating that their transport is also reliant on Abca12
function (Figure 6A). Sphingosine, a breakdown product of
ceramide, was also markedly increased. This was in spite of the
fact that we were unable to resolve intercellular lipid lamellae in
the cornified envelope indicating an intracellular build-up of
these species. Furthermore, significantly increased levels of
cholesterol were observed in the epidermis of Abca12
el12/el12
mice (Figure 6A). No differences were observed in total levels of
phosphatidylinositols, phosphatidylethanolamines, phosphati-
dylcholines, acyl- and lyso-phosphatidylcholines and sphingo-
myelin, suggesting that the defects apparent in our mice, while
more broad and widespread than previously appreciated, were
not a consequence of universal dysregulation of lipid homeo-
Figure 5. Ultrastructural defects in Abca12
el12/el12 mice. Thin sections of Abca12
el12/el12 epidermis illustrated hyperkeratosis and expansion of
the stratum granulosum (A). Nile red staining shows reduced intercellular lamellae lipids at E18.5 (B). In wild type epidermis intercellular lipid lamellae
(white arrow and inset) were noted as well as LBs fusing with the surface of granular cells (red arrow) (C). Lamellar bodies in wild type and
heterozygous embryonic epidermis were normally loaded with lipid (D). In mutant skin, LBs lacked lamellar cargo (E, F arrowheads) but fused with the
granular cell membrane (F; arrows). Mutant epidermis had a normal cornified envelope (G,H) with persistent corneodesmosomes in distal layers of the
stratum corneum (G, H, red arrowheads) and the cornified layer had multiple lipid inclusions (G, black arrowheads). Unlike the uniform contents of
wild type cornified cells mutant cell layers contained vesicular fibrillar structures (I, red arrows) and frequent inclusion bodies (I, black arrows). EM
scale bars in C–F, H, I equal 200 nm and 2 mm in G. C–F and I were stained with ruthenium tetroxide, G and H with osmium tetroxide.
doi:10.1371/journal.pgen.1000192.g005
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lipid levels in Abca12
el12/+ skin, confirming the absence of a
haplo-insufficient phenotype highlighted by our histological
survey.
Defects in Lipid Efflux in Abca12
el12/el12 Fibroblasts
Having established a role for Abca12 in lipid metabolism in
keratinocytes we wondered whether the protein might be more
widely involved in this process. To assess the generality of the
involvement of Abca12 in lipid metabolism, we investigated lipid
efflux from Abca12
el12/el12, Abca12
+/el12 and Abca12
+/+ mouse skin
fibroblasts [27]. To establish the specific involvement of ABC
transporters, cholesterol efflux was compared with or without
activation of LXR, which greatly increases expression of most
ABC transporters including Abca12 [28]. As expected, in wild
type cells activation of LXR resulted in a more than doubling of
cholesterol efflux to apolipoprotein A-I (apoA-I) (Figure 6B). In
Abca12
+/el12 cells the effect was less pronounced, but there was still
a statistically significant increase of the efflux from activated versus
non-activated cells. In contrast, in Abca12
el12/el12 cells activation of
LXR did not result in elevation of cholesterol efflux. Specific,
ABC-dependent cholesterol efflux (i.e. the difference in the efflux
with and without activation) was virtually zero (Figure 6B).
Current models suggest that the cholesterol efflux to apoA-I is fully
controlled by ABCA1 [29]; however, in Abca12
el12/el12 cells there
was no ABC-dependent efflux to apoA-I despite the animals
having functional Abca1. Further, when phospholipid efflux was
compared in Abca12
el12/el12 and Abca12
+/+ fibroblasts, activation of
cells with LXR agonist resulted in a 25% increase in phospholipid
efflux in Abca12
+/+ cells (p,0.05), but no increase in Abca12
el12/el12
(not shown). To determine whether the loss of Abca12 was
affecting the production and abundance of the Abca1 protein in
cells from Abca12
el12/el12 mice we performed western blotting for
Abca1. Strikingly, loss of Abca12, even in a heterozygous state, led
to concomitant decreases in Abca1 protein, providing a functional
link between loss of Abca12 and impairment of cholesterol efflux
(Figure 6C, upper panel). Analysis of transcription of Abca1 in
these cells highlighted 5 fold less expression in mutant versus wild
type fibroblasts but no significant difference between wild type and
heterozygotes (Figure 6C, lower panel).
Impairment of cholesterol efflux is a frequent cause of excessive
accumulation of neutral lipids in cells, especially when exposed to
acetylated low density lipoprotein (AcLDL), a cholesterol donor
for poorly regulated cholesterol uptake pathways. We compared
accumulation of neutral lipids in Abca12
el12/el12, Abca12
+/el12 and
Abca12
+/+ fibroblasts treated or not treated with AcLDL by
Figure 6. Defects in skin lipid composition and cellular lipid efflux mediated by Abca12. Analysis Abca12
el12/el12 epidermal lipids indicate
significant increases in levels of ceramide (Cer), glucoslyceramide (GC), sphingosine (Sph) and free cholesterol in Abca12
el12/el12 skin at E18.5. Total
phosophatidylcholine (PC) and cholesterol ester (CE) levels were unchanged (A, ***p,0.0001; **p,0.001; *p,0.01 versus wilt type epidermis) (A).
Defects in fibroblast cholesterol efflux were assayed using [
3H]cholesterol and incubation in the presence (+) or absence (2)) of the LXR agonist TO-
901317. Means plus or minus standard deviation of quadruplicate determinations are shown. (**p,0.001 versus non activated cells;
*# p,0.001
versus ABCA12
+/+ cells;
*p,0.01 versus ABCA12
2/+ cells) (B). Expression of Abca1 was determined at the protein level by Western blotting (C, upper
panel) and decreases in Abca12 homozygous mutant cells were shown to be in part due to decreases in transcription of Abca1 (C, lower panel, fold
change in transcription relative to el12/el12, ***p,0.0005). Lipid accumulation in fibroblasts the presence or absence of the lipid donor acetylated
LDL (AcLDL) was assayed by Oil Red O staining (magnification 6100) (D).
doi:10.1371/journal.pgen.1000192.g006
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accumulate lipids independently of the presence of AcLDL
indicating that lipid homeostasis pathways successfully cope with
excessive lipid delivery (Figure 6D). Abca12
+/el12 fibroblasts also did
not accumulate lipids in the absence of AcLDL, but there was
visible lipid accumulation in the presence of AcLDL. Abca12
el12/
el12cells accumulated lipids both in the absence and presence of
AcLDL, the accumulation being more severe in the presence of
AcLDL. Thus, lipid homeostasis is severely impaired in Abca12
el12/
el12 fibroblasts.
Discussion
Forward genetic screens in mice remain an important source of
models of genetic disorders in humans. In this report we have used
a forward genetic approach to identify a model of harlequin
ichthyosis which has allowed us to characterise Abca12’s function
as a key regulator of lipid homeostasis and cholesterol transport.
Current recessive ENU mutagenesis approaches to identify
embryonic lethal mutations in the mouse either require the
analysis of large numbers of embryos to identify defects, or the use
of mice carrying engineered balancer chromosomal rearrange-
ments tagged with visible phenotypic markers [30]. While the
latter approach can very efficiently identify all the mutations that
cause lethality between conception and weaning, and has the
advantage of simultaneously isolating and mapping mutations, the
genomic region screened is restricted to that delimited by the
balancer chromosome. We have developed a simple genome-wide
approach which obviates the requirement to dissect embryos and
which simultaneously isolates and maps mutations. We inter-
crossed two inbred mouse strains, one of which was mutagenised
with ENU, established pedigrees from the resultant offspring, and
screened these for regions of the genome under-represented for the
mutagenised genetic background. As a consequence we simulta-
neously identified and mapped lethal mutations in an unbiased
genome wide manner.
Using this approach we have isolated a mouse model of
Harlequin Ichthyosis, a hyperkeratotic and often lethal disease of
the epidermis. We observed many HI features in our Abca12
el12/el12
mice including severe hyperkeratosis, LB defects, absence of
intercellular lamellae, aberrant filaggrin processing, neonatal
death, defects in lipid metabolism, congenital contractures and
the absence of skin barrier function. Studies of HI pathology
suggest that the disease may be grouped into 3 subtypes [18]. The
altered LB structure, absence of keratin VI expression and defects
in filaggrin processing indicate that our mutant is equivalent to
Type 1 HI proposed by this scheme although recent genotype/
phenotype analysis suggests no correlation between mutation and
phenotype [31]. Defects in the CE are characteristic of LI [32,33],
but our EM investigation showed no obvious deficiencies in this
structure. A missense mutation similar to that of our mouse
(glycine to charged amino acid in a highly conserved TM domain
residue) has been shown to cause severe HI [31]. It is highly
unlikely that our model is of LI2, in which missense mutations
have only been found within or near the first nucleotide binding
domain of the protein [10]. This, coupled with the severity of
disease in our mouse, suggests the G1997D mutation severely
affects Abca12 activity although it remains to be determined
whether it mis-localises or has altered transport function, as both
have been observed in TM mutations in ABC family members
causing severe disease [34–36]. The Abca12
el12/el12 phenotype
closely matches a targeted deletion of exon 10 generated by
Lexicon Genetics, an allele in which postnatal lethality and
absence of heterozygous effects were noted (Abca12
tm1Lex, www.
informatics.jax.org). However, the Lexicon study undertook no
characterisation of homozygous animals beyond noting lethality. A
recent similar study by Yanagi et al., demonstrated barrier defects
in mice lacking Abca12 and suggest that postnatal death is a result
of defects in lung function in newborn animals [16]. Our mouse
parallels HI in almost every respect and has allowed us to
investigate several aspects of disease which have been impossible in
the limited patient samples available.
We first examined the temporal progress of disease. Abca12
el12/
el12 mice displayed severe hyperkeratosis around the time of
stratification of the cornified epidermal layer (E16.5). This
phenotype increased in severity as development progressed to
the point where the epidermis restricts the normal growth of the
embryo. Abca12
el12/el12 skin progressively enters a state of
premature differentiation characterised by loss of normal basal
cell architecture, mis-expression of differentiated keratins in basal
keratinocytes, reduction in the size of the spinous cell layer and
expansion of granular layers. We show that the retention of
cornified squames in the upper layers of the epidermis which
contribute to this restrictive epidermis is not due to hyper-
proliferation or alteration in apoptosis. Instead we observe defects
in the deposition of extra-cellular lipid lamellae and in proteolytic
activity in the epidermis, indicating that the hyperkeratosis in our
mice is due to failure to form and shed cornified envelopes from
the skin surface. Our EM studies indicated that this retention was
in part due to persistence of corneodesmosomes into the distal
layers of the epidermis. This retention defect may explain why the
CE’s isolated directly from the skin surface by detergent extraction
were relatively sparse and also exhibit fragility. Our results are
consistent with previous studies indicating that the defects in LB
loading can result in decreases in co-transport of proteases
required for normal desquamation [37] and which has been
suggested as a mechanism by which HI hyperkeratosis might occur
[38]. Our results lend weight to this hypothesis. These defects also
contribute to the loss of barrier function of mutant epidermis. As
with human HI patients [18], defects in proteolytic cleavage of
filaggrin characterise the mice. These defects in the proteolytic
processing of components are almost certainly reflected in the
unusual presence of inclusions and vesicles within the normally
uniform cells of the stratum corneum when examined by EM. In
addition to these defects in the cornified layer, our observation of
differentiation defects in Abca12
el12/el12 mice indicates that defects
in the HI epidermis affect all layers of the skin.
Insights into the mechanisms by which loss of Abca12 function
might affect the skin was revealed by our analysis of lipid species
present in the epidermis. Previous studies have shown that Abca12
is important in controlling glucosylceramide trafficking in
keratinocytes [8], where it localises to the golgi and lamellar
bodies [11], an observation which correlates well with the striking
increase in levels of glucosylceramide in the Abca12
el12/el2
epidermis. However, our investigations of the Abca12
el12/el12 mice
revealed that defects in lipid homeostasis in the skin extend well
beyond glucosylceramide. Despite the absence of intercellular lipid
lamellae we detected significant increases in both ceramide and
free cholesterol in the epidermis. We propose that increases in
ceramide (and indeed sphingosine, a ceramide breakdown
product) might reflect continuing unchecked de-novo synthesis
and accumulation of this species, because of the absence of an
Abca12 mediated trafficking mechanism to remove glucosylcer-
amide from the cell. Cholesterol is also a known cargo of lamellar
bodies [3] and its increased concentration in the epidermis
probably reflects defects in trafficking of LBs or of a failure of
loading this component as a consequence of loss of Abca12. The
ratio of ceramide, cholesterol and fatty acids in the epidermis is
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LB formation [39] and induction of the synthesis machinery for
these compounds is an early response to compromises in barrier
function [40,41]. Consequently the defects in lipid levels in
Abca12 mutant skin might actually be exacerbated by these
positive feedback loops beyond primary defects related to Abca12
transport dysfunction.
We find that the effects of Abca12 mutation are not limited to
keratinocytes. Skin fibroblasts isolated from mutant mice showed
an impairment of their ability to maintain cholesterol efflux to
apoA-I proportional to gene dose. Cholesterol efflux to apoA-I is a
key pathway responsible for maintaining cellular cholesterol
homeostasis and is believed to be fully controlled by another
ABC transporter, ABCA1 [42]. Here we demonstrate that this is
not the case, and that Abca12 is also essential for cholesterol efflux
to apoA-I. Phospholipid efflux was also impaired, consistent with
the currently adopted view of the mechanism of ABCA1-
dependent cholesterol efflux [43]. We demonstrate that in primary
cells from Abca12
el12/el12 mice, loss of Abca12 function results in
decreased transcription of Abca1. The basis of this association
remains unclear but the alteration in transcription may not be the
only explanation of significant ablation of ABCA1-dependent
cholesterol efflux observed in these cells. This is particularly
notable in fibroblasts heterozygous for the el12 mutation, which
have normal levels of Abca1 transcription but which display
significant decreases in Abca1 abundance and in efflux of
cholesterol to apoA-1. Given that many ABC transporters form
homo- or hetero-oligomers and that oligomerisation of Abca1 is
important for its function [44] we speculate that a direct
association between Abca12 and Abca1 might additionally be
essential for functional stabilization of Abca1 and normal
cholesterol efflux to ApoA1. The exact mechanism by which this
occurs remains to be determined. Significantly, fibroblasts lack the
classic LB organelles observed in keratinocytes. Our results
therefore indicate that the Abca12 protein is capable of regulating
the accumulation and efflux of lipids without this highly
specialized organelle.
Impairment of cholesterol efflux led to intracellular accumula-
tion of neutral lipids, most likely cholesteryl esters; in Abca12
el12/el12
cells. These lipids accumulated even in the absence of a challenge
with extra-cellular lipid delivery through AcLDL. This finding has
implications for another important pathology, atherosclerosis.
Accumulation of cholesterol is a crucial element of the
pathogenesis of atherosclerosis and impairment of cholesterol
efflux, especially against a background of hypercholesterolemia, is
a key contributor to the risk of atherosclerosis and coronary heart
disease. Polymorphisms in ABCA1 are one of the strongest factors
affecting plasma levels of high density lipoprotein [29] and risk of
cardiovascular disease [45]. Our findings suggest that Abca12 is
also required for the cholesterol efflux pathway to function and
therefore should be taken into account when investigating
mechanisms of atherosclerosis or considering targets for its
treatment. Abca12 is expressed in primary macrophages at levels
approximately 10 fold greater than the fibroblasts in which we
have demonstrated cholesterol efflux defects in this study
(unpublished observations). The severity and rarity of HI have
precluded studies addressing associations between HI and heart
disease, but the availability of this mouse model will allow us to
investigate this relationship.
We have detailed a genetic screening protocol which
concurrently identifies and maps postnatal or embryonic lethal
mutations in an unbiased genome wide manner. This approach
has allowed us to characterise an animal model of HI, providing a
unique avenue by which to pursue therapeutic interventions for
this and other ichthyoses. Our results demonstrate that HI should
be viewed as a disease in which defects in Abca12 function lead to
profound dysregulation of lipid metabolism in the epidermis.
Furthermore we show in fibroblasts that the protein is a key
regulator of cholesterol efflux, an observation with direct
relevance to other defects of lipid homeostasis, including
atherosclerosis.
Materials and Methods
ENU Mutagenesis Screen
Male 129/Sv mice were injected with a total dose of 200–
400 mg/kg of N-Ethyl-N-Nitrosourea (ENU) in 3 weekly doses.
ENU-treated males were mated with a C57BL/6 female and male
G1 mice were crossed to C57BL/6 females. A G2 daughter was
then backcrossed to her G1 father to produce G3 progeny for
typing using 139 polymorphic markers spaced evenly throughout
the genome [46]. Genotyping the G2 female allowed us to identify
those markers that were heterozygous and hence informative in
the final screen of G3 mice. Embryonic lethal mutations therefore
manifest as a reduction in the expected frequency of 129/Sv
homozygosity in adult animals. Those pedigrees in which no 129/
Sv homozygosity of an informative SSLP was observed in G3 mice
at weaning were recovered by performing IVF using cryopre-
served G1 male sperm and eggs from C57BL/6 females. G2 mice
heterozygous for the region of interest were then inter-crossed and
their progeny analysed to determine whether 129/Sv homozygos-
ity of linked markers was also absent in the second cohort. In these
cases, the location of the embryonic lethal mutation was refined by
genotyping key recombinants with additional polymorphic
markers. Genomic DNA was extracted from tail biopsies and
subjected to PCR amplification with oligonucleotide primers
designed using the GABOS/GAFEP program (http://bioinf.wehi.
edu.au/gabos/index.php). To remove primers and unincorporat-
ed nucleotides, post-PCR reactions were treated with ExoSAP-IT
(USB) according to the manufacturer’s instructions and filtered
through Sephadex columns. Amplicons were then sequenced
directly using BigDye Terminator v3.0 (Applied Biosystems).
TEWL and Skin Permeability Assays
Assays of epidermal barrier function were performed essentially
as previously described [17]. Gravimetric TEWL assays were
performed using skin samples excised from the lateral thoraco-
lumbar region of E18.5 embryos. Embryos and skin were
photographed with a Zeiss Axiocam camera mounted on a Zeiss
Stemi microscope. Comparison of TEWL was made using logistic
regression models. All other statistical analyses were performed
using the statistical software package STATA Version 7 (Stata
Corporation USA).
Cornified Envelope Preparations
Cornified envelopes and epidermal protein samples were
prepared as previously described [47,48]. Size calculations were
performed using the Image J software package (NIH).
Immunohistochemistry
Nile Red staining was performed as previously described [49].
IHC and IF were performed on citrate antigen retrieved paraffin
embedded tissues or on frozen sections. Antibodies used were:
rabbit anti-cytokeratin 14, -cytotkeratin 10, -cytokeratin 6, -
filaggrin and -loricrin (Covance, 1:1000); mouse anti-keratin 14
(1:200, LL002, gift from Fiona Watt); goat anti-Abca12 (Santa
Cruz Biotechnology, 1:50). Secondary antibodies were from
Molecular Probes. Samples were imaged by epifluorescence on
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microscope. Cell proliferation and differentiation were assayed by
counting phospho-histone H3
+ and K14
+/K10
+ positive basal
interfollicular keratinocytes in multiple fields under 206 magni-
fication (n=15 and 7 respectively).
Transmission Electron Microscopy
Mid-dorsum skin was processed for EM as described [20] with
minor modifications. Following fixation and cryoprotection,
samples were OCT embedded, frozen on dry ice and 40 mm
sections cut using a Leica CM 3050 S cryostat. Washed samples
were post-fixed with 0.2% ruthenium tetroxide (Polysciences,
USA), 0.5% potassium ferrocyanide in 0.1 M sodium cacodylate,
pH 7.4 in the dark for 60 min. Following rinsing in water, samples
were dehydrated in an alcohol series and embedded in Spurrs
resin. Sections were cut using a Leica Ultracut S ultra-microtome,
mounted on copper grids and contrasted with methanolic uranyl
acetate and aqueous lead citrate before imaging in a JEOL 1011
TEM with a MegaView III CCD cooled digital camera (Soft
Imaging Systems, Germany).
Whole Epidermis Lipid Analysis
All solvents were of HPLC grade and were used without further
purification. N-Palmitoyl-d3-glucosylceramide (GC 16:0(d3)) and
N-palmitoyl-d3-lactosylceramide (LC 16:0(d3)) were from Matreya
Inc. (Pleasant Gap, USA). Sphingosine (Sph, 17:1 base), ceramide
(Cer) 17:0, sphingomyelin (SM)16:0(d31) and phosphatidylcholine
(PC) 17:0/17:0 were from Avanti Polar Lipids (Alabaster, USA),
Cholesteryl ester (CE) 17:0 was from Mp Biomedicals (Seven Hills,
NSW, Australia). Lipid analysis was performed independently on 7
Abca12
+/+,8Abca12
el12/+ and 6 Abca12
el12/el12 embryos. E18.5 fetus
skins were incubated in phosphate buffered saline containing
5 mM EDTA for 1 h at 37uC. The epidermal layer was then
peeled from the skin with tweezers, weighed and homogenized in
1.0 ml of PBS using a dounce homogenizer. Protein determination
was performed using the Micro BCA Protein Assay Kit (Pierce,
Rockford, Il, USA). Total cholesterol was determined using the
Amplex Red Cholesterol Assay Kit (Invitrogen, Mount Waverly,
Vic, Australia). Total lipids were extracted from tissue homoge-
nates (100 mL containing approximately 100 mg protein) accord-
ing to established methods [50], incorporating 400 pmol of each of
the following internal standards: GC 16:0(d3), LC 16:0(d3) Sph
(17:1 base), Cer 17:0, SM16:0(d31), PC 14:0/14:0 and CE 17:0.
Lipid extracts were reconstituted in 200 mL 10 mM, NH4COOH
in methanol. Lipid analysis was performed by liquid chromatog-
raphy, electrospray ionisation-tandem mass spectrometry (LC ESI-
MS/MS) using a HP 1100 liquid chromatography system
combined with a PE Sciex API 2000 Q/TRAP mass spectrometer
with a turbo-ionspray source (250uC) and Analyst 1.4.2 data
system. LC separation of lipids was performed on an Alltima C18,
3 um, 5062.1 mm column using the following gradient condi-
tions; 70% A reducing to 0% A over three minutes followed by
5 minutes at 0% A, a return to 70% A over 0.1 minute then
1.9 minutes at 70% A prior to the next injection. Solvent A and B
consisted of tetrahydrofuran:methanol:water in the ratios
(30:20:50) and (70:20:10) respectively, both containing 10 mM
NH4COOH. Quantification of individual species of Sph, Cer,
GC, LC, SM, PC and CE was performed using multiple-reaction
monitoring (MRM) in positive ion mode. MRM product ions used
were m/z 264 [sphingosine–H2O]
+ for sphingosine, Cer, GC and
DHC, m/z 184 [phosphocholine]
+ for SM, PC and m/z 369
[cholesterol-H2O]
+ for CE. Each ion pair was monitored for
50 ms with a resolution of 0.7 amu at half-peak height and
averaged from continuous scans over the elution period. Lipid
concentrations were calculated by relating the peak area of each
species to the peak area of the corresponding internal standard.
Isolation of Embryonic Skin Fibroblasts
The skin was separated from the mouse embryos (last week of
gestation). Skin tissue was finely minced, resuspended in 0.05%
Trypsin/EDTA solution, incubated for 30 min at 37uC, vigor-
ously shaken, incubated for another 10 min at 37uC and
neutralized with medium containing 10% FBS. Cells were seeded
and incubated overnight in CO2 incubator before unattached cells
and debris were washed out.
qPCR Analysis of Abca1 Expression
Quantitative expression of Abca1 was determined by qPCR from
cDNA transcribed from Trizol prepared sample total RNA and
amplification using SYBR GreenER PCR mix (Invitrogen) by
primer sequences previously optimized for this approach [51].
Assays were performed in triplicate and standardized to an
internal 18S rRNA control.
Lipid Efflux Assays
Human HDL (1.085,d,1.21) and apoA-I were isolated from
pooled normolipidemic human plasma supplied by Red Cross as
described previously [52]. LDL was purified from human plasma
by sequential centrifugation and acetylated as described by Basu et
al. [53]. Cholesterol and phospholipid efflux were assessed as
described previously [54]. Briefly, fibroblasts were incubated in
labeling medium containing [
3H]cholesterol (75 kBq/ml) or
[methyl-
14C] choline (0.2 MBq/ml) for 48 hours. Cells were
then incubated for 18 hr in serum-free medium in the presence or
absence of the LXR agonist TO-901317 (final concentration
4 mM) to stimulate expression of ABC transporters and cholesterol
efflux. Cells were then washed with PBS and incubated for 2 h in
either serum-free medium alone (blank) or in serum-free medium
supplemented with 30 mg/ml of lipid-free apoA-I. For cholesterol
efflux analysis, aliquots of medium and cells were counted. For
phospholipid efflux lipids were extracted from cells and medium
[50] and counted. The efflux was calculated as radioactivity in the
medium/(radioactivity in the medium+radioactivity remaining in
the cells)6100%. Non-specific efflux (i.e. the efflux in the absence
of acceptor) was subtracted.
Oil Red O Staining
Cells were incubated in the presence of TO-901317 (final
concentration 4 mM) and in the presence or absence of AcLDL
(10 mg/ml) in serum-containing medium for 18 hrs. After washing
with PBS, cells were fixed in 3.7% formaldehyde for 2 min,
washed with water, and incubated at room temperature for 1 h
with Oil Red O working solution (Fisher Biotech).
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